NeueHealth, Inc. (NYSE:NEUE) CFO Sells $29,979.52 in Stock

NeueHealth, Inc. (NYSE:NEUE) CFO Jay Matushak sold 4,448 shares of NeueHealth stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $6.74, for a total value of $29,979.52. Following the completion of the sale, the chief financial officer now owns 41,592 shares in the company, valued at $280,330.08. This represents a 9.66 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Jay Matushak also recently made the following trade(s):

• On Tuesday, March 11th, Jay Matushak sold 814 shares of NeueHealth stock. The shares were sold at an average price of $6.85, for a total value of $5,575.90.
• On Friday, March 7th, Jay Matushak sold 1,860 shares of NeueHealth stock. The stock was sold at an average price of $7.19, for a total value of $13,373.40.
• On Monday, January 6th, Jay Matushak sold 4,970 shares of NeueHealth stock. The stock was sold at an average price of $7.33, for a total value of $36,430.10.

NeueHealth Trading Down 5.6 %

NEUE opened at $4.85 on Thursday. The stock’s 50-day moving average price is $7.11 and its 200 day moving average price is $6.00. NeueHealth, Inc. has a 12-month low of $3.79 and a 12-month high of $7.66. The firm has a market cap of $40.18 million, a price-to-earnings ratio of -0.09 and a beta of 0.56.

Hedge Funds Weigh In On NeueHealth

Hedge funds have recently bought and sold shares of the company. Partners Group Holding AG purchased a new stake in NeueHealth during the 3rd quarter worth about $463,000. Virtu Financial LLC purchased a new stake in NeueHealth during the 4th quarter worth about $76,000. Finally, Northern Trust Corp increased its holdings in NeueHealth by 66.8% during the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after purchasing an additional 13,074 shares during the period. Institutional investors and hedge funds own 63.88% of the company’s stock.

Analyst Ratings Changes

Separately, Royal Bank of Canada decreased their target price on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research note on Monday, December 9th.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.